Page 28 - Revista SPORL - Vol 45. Nº2
P. 28
MARIA ADELINA COSTA; RUI MEDEIROS
15 Medeiros R, Vosconcelos A, Costa S, dents. Philadelphia, PA:
Pinto D, Ferreiro P, lobo F, Morais A, WB Saunders Co; 1993.
Oliveira ], Lopes C. Metabolic susceptibi- 22 Perez CA, Brody 1W. Principles and
lity genes and prostate cancer risk in o Practice of radiation Oncology. Philadel-
southern european population: the role of phia, PA: JB lippincott Co; 2004.
glutathione S-transferases GSTM1 , GSTM3 23 Coleman CN, Stevenson MA, Bump E,
and GSTI'1 genetic polymorphisms. Prosf Colderwood S, Poloyoor S, Price B,
tote. 2004 Mar 1; 58(4): 414-20. 9 Shoh'nan TD. Molecular and cellular bio-
16 Medeiros R, Pereira D, Afonso N, Palmei- logy. In: Gunderson Ll, Topper JE, editors.
ro C, Faleiro C, AFonso-lopes C, Freitas- Clinical radiation oncology. Philadelphia:
-Si|va M, Vasconcelos A, Costa 5, Osorio Chmchill livingstone. 2000; pp42-ó3.
T, Lopes C. Plotinum/poclitoxel based 24 Reed J. Dysregulotion of apoptosis in can-
chemotherapy in advanced ovarian car- cer. J Clin Oncol. 1999; 17(9): 2941-53.
cinoma: glutathione S-transferose genetic 25 Irwin M, Koelin WG. P53 family update:
polymorphisms os predictive biomarkers p73 and p63 develop their own identi-
of disease outcome. Int J Clin Oncol. ties. Cell Growth Differ. 2001; 12:337-49.
2003 Jun; 8(3): 156-161. 26 Cai YC, Yang GY, Wong LD, Zhoo X,
17 Benhomou S, Jin Lee W, A.—I(arin, et ol. Song YI., Seril DN, Lico J, Xing EP, Yong
Meta and pooled analyses oÍ the effects CS Molecular alterations oÍ p73 in hu-
of glutathione S-transterase M1 polymor- man esophageal squamous cell carcino
phisms and smoking on lung cancer risk. mas: loss of heterozygosity occurs fre-
Carcinogenesis. 2002; vol. 23(8): quently; loss of imprinting and elevation
1343-1350. of p73 expression may be related to de-
18 Martins G, Alves M, Dios J, et al. Gluta- tective p53. Carcinogenesis.
thione S-tronsferase u polymorphism and 2000; 21(4): 683-9.
gastric cancer in the Portuguese population. 27 Irwin M, Morin MC, Phillips AC, Seelon
Biomorkers. 1998; vol. 3(ó): 441-447. RS, Smith DI, Liu W, Flores ER, Tsoi KY,
19 Silva N. Diagnóstico do cancro oral e Jocks T, Vousden KH, Koelin WG. Role
lesões pré-concerosas. Rev Port Estomatol (or the p53 homologue p73 in E2F-1-in-
Cir Maxilotoc. 1997; 38(3): 137-147. duced opoptosis. Nature.
20 Bordakci F, Conboy E, Degerli N, Cobcm 2000; 407: 645-8.
L, Conbay EI. Relationship of tobacco 28 White E, Prives C. DNA damage enables
smoking with GSTM1 gene ponmorphism p73. Nature. 1999; 734-5.
in luringeol cancer. Journal of Cellular 29 Craveiro R, Costa S, Pinto D, Solgodo L,
and Molecular Medicine. Carvalho L, Castro C, Bravo I, Lopes C,
2003 Ju|y~$eptember. Silva l, Medeiros R. TP73 alterations in
21 Rubin P. Clinical Oncology. A Multidisci- cervical carcinoma. Cancer Genet Cyto-
plinary Approach for Physicians and Stu- genet. 2004 Apr 15; 150(2): 1 16-21.
